For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says.

It is estimated to reach $1.93 billion by 2029, growing at a compound annual growth ... Several leading businesses in the targeted alpha-therapy market are concentrating their efforts on creating ...

Early research suggests a brain test may predict whether antidepressants will cause sexual dysfunction. There has never been ...

Novo Nordisk A/S faces competition in obesity drug development space; pipeline innovations & long-term outlook. Read why NVO ...

Intraoperative floppy iris syndrome is a clinical situation encountered during phacoemulsification characterized by loss of ...

Immatics is advancing Anzu-cel, a T-cell receptor therapy for melanoma with potential for significant annual revenue. Learn ...

Many patients with long COVID experience brain fog, but the reasons are not well understood. A new study links brain fog to a ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

"GLP-1 receptor agonists seem to have very similar effects in mice and humans," says Mehal. "If these results are also reproduced in humans, people using GLP-1 receptor agonists might be drinking an ...

Lilly to present new clinical data for Verzenio and multiple novel pipeline programMEs at the 2025 ESMO annual meeting: Indianapolis Tuesday, October 14, 2025, 09:00 Hrs [IST] Eli ...